These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30807227)

  • 41. Broncho-Pleural Fistula with Hydropneumothorax at CT: Diagnostic Implications in Mycobacterium avium Complex Lung Disease with Pleural Involvement.
    Yoon HJ; Chung MJ; Lee KS; Kim JS; Park HY; Koh WJ
    Korean J Radiol; 2016; 17(2):295-301. PubMed ID: 26957917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
    Moon SM; Jhun BW; Baek SY; Kim S; Jeon K; Ko RE; Shin SH; Lee H; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Respir Med; 2019 May; 151():1-7. PubMed ID: 31047103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of Mycobacterium avium Complex (MAC).
    Griffith DE
    Semin Respir Crit Care Med; 2018 Jun; 39(3):351-361. PubMed ID: 30071550
    [No Abstract]   [Full Text] [Related]  

  • 44. Proton Magnetic Resonance Imaging for Initial Assessment of Isolated Mycobacterium avium Complex Pneumonia.
    Chung JH; Huitt G; Yagihashi K; Hobbs SB; Faino AV; Bolster BD; Biederer J; Puderbach M; Lynch DA
    Ann Am Thorac Soc; 2016 Jan; 13(1):49-57. PubMed ID: 26633593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study.
    Jhun BW; Moon SM; Jeon K; Kwon OJ; Yoo H; Carriere KC; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31619468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of Fluoroquinolones as Substitutes for Ethambutol or Rifampin in the Treatment of Mycobacterium avium Complex Pulmonary Disease According to Radiologic Types.
    Lee JH; Park YE; Chong YP; Shim TS; Jo KW
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0152221. PubMed ID: 34930036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic
    Nakagawa T; Hashimoto H; Yagi M; Kogure Y; Sekimizu M; Saito AM; Ogawa K; Inoue Y
    BMJ Open Respir Res; 2019; 6(1):e000434. PubMed ID: 31258920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease by Single Bacterial Isolation Plus Anti-GPL-Core IgA Antibody.
    Kawasaki T; Kitada S; Fukushima K; Akiba E; Haduki K; Saito H; Nitta T; Kawano A; Miyazaki A; Nii T; Kuge T; Koba T; Matsuki T; Tsujino K; Miki K; Maekura R; Kida H
    Microbiol Spectr; 2022 Feb; 10(1):e0140621. PubMed ID: 34985326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease.
    Kitada S; Uenami T; Yoshimura K; Tateishi Y; Miki K; Miki M; Hashimoto H; Fujikawa T; Mori M; Matsuura K; Kuroyama M; Maekura R
    Int J Tuberc Lung Dis; 2012 May; 16(5):660-4. PubMed ID: 22410245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease.
    Wallace RJ; Iakhiaeva E; Williams MD; Brown-Elliott BA; Vasireddy S; Vasireddy R; Lande L; Peterson DD; Sawicki J; Kwait R; Tichenor WS; Turenne C; Falkinham JO
    J Clin Microbiol; 2013 Jun; 51(6):1747-52. PubMed ID: 23536397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Bacteriological and pathological analysis on the pathogenetic factors for cavitary and nodular bronchiectatic type of pulmonary Mycobacterium avium-intracellulare complex disease].
    Okumura M; Iwai K; Yano I; Takahashi M; Kasumi Y; Tanaka S; Yoshiyama T; Ogata H; Nakajima Y; Azuma A; Kudoh S
    Nihon Kokyuki Gakkai Zasshi; 2006 Feb; 44(2):91-8. PubMed ID: 17228801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum Krebs von den Lungen-6 level in the disease progression and treatment of Mycobacterium avium complex lung disease.
    Asakura T; Kimizuka Y; Nishimura T; Suzuki S; Namkoong H; Masugi Y; Sato Y; Ishii M; Hasegawa N
    Respirology; 2021 Jan; 26(1):112-119. PubMed ID: 32602203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proposed definitions for epidemiologic and clinical studies of Mycobacterium avium complex pulmonary disease.
    Plotinsky RN; Talbot EA; von Reyn CF
    PLoS One; 2013; 8(11):e77385. PubMed ID: 24265675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of clinical and radiographic characteristics between nodular bronchiectatic form of nontuberculous mycobacterial lung disease and diffuse panbronchiolitis.
    Park HY; Suh GY; Chung MP; Kim H; Kwon OJ; Chung MJ; Kim TS; Lee KS; Koh WJ
    J Korean Med Sci; 2009 Jun; 24(3):427-32. PubMed ID: 19543504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease.
    Lee BY; Kim S; Hong Y; Lee SD; Kim WS; Kim DS; Shim TS; Jo KW
    Antimicrob Agents Chemother; 2015; 59(6):2972-7. PubMed ID: 25753634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Difference in drug susceptibility distribution and clinical characteristics between
    Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y
    J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797
    [No Abstract]   [Full Text] [Related]  

  • 57. Neutrophil-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio According to the Radiologic Severity of
    Kim MA; Park YE; Chong YP; Shim TS; Jo KW
    J Korean Med Sci; 2022 Oct; 37(40):e292. PubMed ID: 36254530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insufficient serum L-ficolin is associated with disease presence and extent of pulmonary Mycobacterium avium complex disease.
    Kobayashi T; Kuronuma K; Saito A; Ikeda K; Ariki S; Saitou A; Otsuka M; Chiba H; Takahashi S; Takahashi M; Takahashi H
    Respir Res; 2019 Oct; 20(1):224. PubMed ID: 31638993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple Cavitary Pulmonary Nodules Caused by Mycobacterium intracellulare.
    Yoo SH; Kim SR; Choi JY; Choi JW; Ko YM; Jang SH; Park JK; Sung YG; Park YJ; Oh SY; Bahk SY; Lee JH; Kim MS
    Korean J Fam Med; 2016 Jul; 37(4):248-52. PubMed ID: 27468344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical course and risk factors of mortality in Mycobacterium avium complex lung disease without initial treatment.
    Wang PH; Pan SW; Shu CC; Chen CY; Wei YF; Cheng SL; Wang HC; Yu CJ
    Respir Med; 2020 Sep; 171():106070. PubMed ID: 32658834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.